 |
|
New studies add weight to link between pre-eclampsia and heart disease
November 02, 2007Pre-eclampsia and the risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis
Two studies, published together on bmj.com today, add further weight to the theory that pre-eclampsia and cardiovascular diseases may share common causes or mechanisms.
The first study finds that women who have had pre-eclampsia during pregnancy have a more than two fold higher risk of heart disease in later life, while the second shows that women with cardiovascular risk factors that are present years before pregnancy may be predisposed to pre-eclampsia.
Pre-eclampsia is a serious condition where abnormally high blood pressure and other disturbances develop in the second half of pregnancy. It affects about 5% of all first-time pregnancies and is dangerous for both mother and child.
In the first study, researchers in London analysed 25 studies involving over 3 million women to calculate the future health risks of women who have had a pregnancy affected by pre-eclampsia that is likely explained by the association with heart disease.
They found a small increase in overall mortality among women who had had pre-eclampsia. Women with a history of pre-eclampsia also had an almost four fold increased risk of high blood pressure (hypertension) and a two fold increased risk of fatal and non-fatal ischaemic heart disease, stroke, and blood clots (venous thromboembolism) in later life.
They found no increase in risk of any cancer, including breast cancer, suggesting a specific relationship between pre-eclampsia and cardiovascular disease.
The authors explain that, since the risk of a cardiovascular event increases with age, and assuming that the effect of the pre-eclampsia is independent of other risk factors, absolute risk at age 50-59 years would be around 8% without and 17% with a history of pre-eclampsia and at 60-69 years the risk would be 14% without and around 30% for a woman with a history of pre-eclampsia.
This suggests that a woman with pre-eclampsia might become eligible for preventative therapies at an earlier age than would otherwise be the case.
The mechanism underlying this association remains to be defined, but whatever its nature, a history of pre-eclampsia should be considered when evaluating risk of cardiovascular disease in middle aged women, they conclude.
In the second study, researchers in Norway examined whether cardiovascular risk factors assessed before conception predict pre-eclampsia.
3,494 women were included in the analysis. Several cardiovascular risk markers, including blood pressure, cholesterol and blood sugar levels, weight, and body mass index, were recorded before pregnancy.
133 (3.8%) of these women had a pregnancy complicated by pre-eclampsia. After adjusting for factors such as smoking and social status, the odds of pre-eclampsia were seven times greater in women with high pre-pregnant blood pressure, total cholesterol and blood sugar levels compared to women with readings in the normal range.
Furthermore, a family history of high blood pressure, ischaemic heart disease, or diabetes was each associated with a doubling in risk, while overweight and obese women also had a higher risk compared to women of normal weight. Women who used oral contraceptives before pregnancy had half the risk of pre-eclampsia compared to never or previous users.
These results show that unfavourable cardiovascular risk factors that were present years before pregnancy are strong predictors of pre-eclampsia, suggesting that pre-eclampsia and cardiovascular diseases may share a common origin, say the authors.
However, this does not rule out the possibility that the pre-eclamptic process itself may also contribute to subsequent cardiovascular risk, they conclude.
An accompanying editorial says that guidelines for prevention of cardiovascular disease are appropriate for all women, while future research must investigate whether women with previous pre-eclampsia should have their cardiovascular risk markers treated earlier and more aggressively (or both).
BMJ-British Medical Journal
Pre-eclampsia is a serious condition where abnormally high blood pressure and other disturbances develop in the second half of pregnancy. It affects about 5% of all first-time pregnancies and is dangerous for both mother and child.
In the first study, researchers in London analysed 25 studies involving over 3 million women to calculate the future health risks of women who have had a pregnancy affected by pre-eclampsia that is likely explained by the association with heart disease.
They found a small increase in overall mortality among women who had had pre-eclampsia. Women with a history of pre-eclampsia also had an almost four fold increased risk of high blood pressure (hypertension) and a two fold increased risk of fatal and non-fatal ischaemic heart disease, stroke, and blood clots (venous thromboembolism) in later life.
They found no increase in risk of any cancer, including breast cancer, suggesting a specific relationship between pre-eclampsia and cardiovascular disease.
The authors explain that, since the risk of a cardiovascular event increases with age, and assuming that the effect of the pre-eclampsia is independent of other risk factors, absolute risk at age 50-59 years would be around 8% without and 17% with a history of pre-eclampsia and at 60-69 years the risk would be 14% without and around 30% for a woman with a history of pre-eclampsia.
This suggests that a woman with pre-eclampsia might become eligible for preventative therapies at an earlier age than would otherwise be the case.
The mechanism underlying this association remains to be defined, but whatever its nature, a history of pre-eclampsia should be considered when evaluating risk of cardiovascular disease in middle aged women, they conclude.
In the second study, researchers in Norway examined whether cardiovascular risk factors assessed before conception predict pre-eclampsia.
3,494 women were included in the analysis. Several cardiovascular risk markers, including blood pressure, cholesterol and blood sugar levels, weight, and body mass index, were recorded before pregnancy.
133 (3.8%) of these women had a pregnancy complicated by pre-eclampsia. After adjusting for factors such as smoking and social status, the odds of pre-eclampsia were seven times greater in women with high pre-pregnant blood pressure, total cholesterol and blood sugar levels compared to women with readings in the normal range.
Furthermore, a family history of high blood pressure, ischaemic heart disease, or diabetes was each associated with a doubling in risk, while overweight and obese women also had a higher risk compared to women of normal weight. Women who used oral contraceptives before pregnancy had half the risk of pre-eclampsia compared to never or previous users.
These results show that unfavourable cardiovascular risk factors that were present years before pregnancy are strong predictors of pre-eclampsia, suggesting that pre-eclampsia and cardiovascular diseases may share a common origin, say the authors.
However, this does not rule out the possibility that the pre-eclamptic process itself may also contribute to subsequent cardiovascular risk, they conclude.
An accompanying editorial says that guidelines for prevention of cardiovascular disease are appropriate for all women, while future research must investigate whether women with previous pre-eclampsia should have their cardiovascular risk markers treated earlier and more aggressively (or both).
BMJ-British Medical Journal
Pre-eclampsia Current Events and Pre-eclampsia News RSSFaithful mothers have healthier babies
Faculty of 1000 reviewers examine a study from New Zealand on whether prolonged exposure to the father's semen protects new mothers against pre-eclampsia and having an undersized baby
Pregnant women risk early delivery from using psychiatric medication
The odds triple for premature child delivery pregnant women with a history of depression who used psychiatric medication, according to a new study.
New link between pre-eclampsia and diet
A chemical compound found in unpasteurised food has been detected in unusually high levels in the red blood cells of pregnant women with the condition pre-eclampsia.
Stuff of stink bombs investigated for role in pregnancy
Scientists at the University of Leicester are investigating how the stuff of stink bombs and flatulence could play a critical role in the human reproductive system.
Obesity raises risk of complications in pregnancy, study shows
Expectant mothers who are obese are much more likely to suffer from minor complications such as heart burn and chest infections during pregnancy, a study suggests.
Women with endometriosis need special care during pregnancy to avoid risk of premature birth
The largest study to date of endometriosis in pregnant women has found that the condition is a major risk factor for premature birth.
Ben-Gurion U researchers -- bariatric surgery minimizes pregnancy complications for obese women
Women who undergo bariatric surgery to treat obesity will reduce the risk of medical and obstetric complications when they become pregnant, according to a study by researchers from Ben-Gurion University of the Negev's (BGU) Faculty of Health Sciences.
Pregnancy disorder signals need to screen for heart disease, study shows
High blood pressure experienced during pregnancy could be a woman's earliest warning that she is at risk of developing heart disease - the number one killer of Canadian women - says Queen's University professor of Obstetrics and Gynecology, Graeme Smith.
New research on pre-eclampsia in mice may have important implications for humans
In a new March of Dimes-funded study of pre-eclampsia, a serious and potentially deadly disorder that affects about 5 percent of pregnancies, researchers have found results in mice that may have important implications for diagnosis and treatment in humans.
Clues to ancestral origin of placenta emerge in Stanford study
Researchers at the Stanford University School of Medicine have uncovered the first clues about the ancient origins of a mother's intricate lifeline to her unborn baby, the placenta, which delivers oxygen and nutrients critical to the baby's health.
More Pre-eclampsia Current Events and Pre-eclampsia News Articles
 |
Pre-eclampsia: Etiology and Clinical Practice by Fiona Lyall (Editor), Michael Belfort (Editor) Pre-eclampsia is one of the leading causes of death and disability in mothers and babies. Over four million women worldwide will develop the disorder every year. This book, written by an international team of experts, focuses on both the scientific basis of pre-eclampsia and its management. The basic science section contains up-to-date reviews of the most exciting research developments in pre-eclampsia. The clinical chapters provide a comprehensive review of the pertinent literature, highlighting recent data and new ideas or developments in current management. There is a section in each chapter (where relevant) that deals with practical management, giving clinicians a formulated treatment plan that they can implement directly. The book will be of interest to all professionals interested... |
 |
Omron Elite 7300W Womens Avanced Blood Pressure Monitor by Omron FDA approved for women during pregnancy. Clinically validated for use by pregnant women, who are at significant risk for high blood pressure and pre-eclampsia |
|
Pre-Eclampsia: The Hypertensive Disease of Pregnancy by Ian Macgillivray (Author) | |
 |
Baby Nathan by Denise Davis (Author) Denise Davis, MSW, LSW, was born in Hammond, Indiana, in 1972. She was raised by a single mother since the age of ten when her father died in a tragic accident. Focusing on her academics, she worked hard during her school years and earned a master’s degree in social work from Loyola University in 2002. She currently works in Merrillville, Indiana, providing psychotherapy to children and adolescents. She is a wife and mother of four children, one of which was a stillborn twin named Nathan. This is Nathan’s story, how his short life and death sent Denise on the most challenging journey of her life. |
 |
Recurrent Miscarriage And Pre-eclampsia: The Roles Played By The Immune System And Antioxidants by Rhoda Wilson (Author) This book examines the role of antioxidants and of the immune system in the pathogenesis of pre-eclampsia and recurrent miscarriage. Whilst many papers have discussed the role of antioxidants in pre-eclampsia and, that of the immune system, hitherto publication has not considered the two simultaneously. The role of the immune system in recurrent miscarriage has been the subject of many papers but whether antioxidants play a part in miscarriage has been less well studied. In many ways the problems encountered in the two disorders are similar, and this book brings them together. |
 |
Pre-eclampsia: Webster's Timeline History, 1951 - 2007 by Icon Group International (Author) |
|
Pre-eclampsia: risks at antenatal booking and recurrence across generations.(ROUND UP: Research): An article from: Reproductive Health Matters by Gale Reference Team (Author) This digital document is an article from Reproductive Health Matters, published by Thomson Gale on November 1, 2006. The length of the article is 510 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Pre-eclampsia: risks at antenatal booking and recurrence across generations.(ROUND UP: Research) Author: Gale Reference Team Publication: Reproductive Health Matters (Magazine/Journal) Date: November 1, 2006 Publisher: Thomson Gale Volume: 14 Issue: 28 Page: 214(1) Distributed by Thomson... | |
|
Pre-eclampsia: The Facts: The Hidden Threat to Pregnancy (Oxford Medical Publications) by Chris Redman (Author), Isabel Walker (Author) Pre-eclampsia is the development of hypertension during pregnancy and the most common and the most potentially serious complication of pregnancy. It affects one out of every ten pregnancies, yet there is little known about the disease. This work informs pregnant women, family practitioners, and midwives of this usually symptomless, but often dangerous condition. It includes several illuminating case histories. Written by an expert in the field and a medical journalist who has suffered from pre-eclampsia, this book is a comprehensive and accessible portrait of the disease. It details all that is currently known about the origins and treatment of pre-eclampsia, and also provides advice for pregnant women. | |
|
Embarazadas: cuidado con la preclampsia.(TT: Pregnant women: carefull with pre-eclampsia): An article from: Contenido by Inés Olguín (Author) This digital document is an article from Contenido, published by Editorial Contenido, S.A. de C.V. on November 1, 1997. The length of the article is 1077 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Embarazadas: cuidado con la preclampsia.(TT: Pregnant women: carefull with pre-eclampsia) Author: Inés Olguín Publication: Contenido (Magazine/Journal) Date: November 1, 1997 Publisher: Editorial Contenido, S.A. de C.V. Issue: n413 Page: p70(3) Distributed by Thomson... | |
|
Antiretroviral therapy in HIV positive pregnant women and risk of pre-eclampsia, fetal death, preterm birth and low birthweight.(ROUND UP: Maternal Mortality ... An article from: Reproductive Health Matters by Gale Reference Team (Author) This digital document is an article from Reproductive Health Matters, published by Thomson Gale on November 1, 2007. The length of the article is 447 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Antiretroviral therapy in HIV positive pregnant women and risk of pre-eclampsia, fetal death, preterm birth and low birthweight.(ROUND UP: Maternal Mortality and Morbidity)(Human immunodeficiency virus) Author: Gale Reference Team Publication: Reproductive Health Matters (Magazine/Journal) Date: November 1, 2007 Publisher: Thomson Gale Volume: 15 Issue: 30 Page:... |
| © 2009 BrightSurf.com |